Asked by: Carla Lockhart (Democratic Unionist Party - Upper Bann)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of whether abortion providers, including British Pregnancy Advisory Service and Marie Stopes InternationaI Reproductive Choices, provide clear and comprehensive information to pregnant women on the full range of childcare and maternity related financial support available to them.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department’s required standard operating procedures for the approval of independent sector places for the termination of a pregnancy, an abortion, in England sets out that women requesting termination of pregnancy must be given impartial, accurate, and evidence-based information, both verbal and written, delivered in a clear, understandable, and non-judgemental way. This includes informing women about their options so that they can make an informed choice about their preferred course of action. As early as possible, women should be provided with detailed information, including on alternatives to abortions such as adoption and motherhood. Their choice should be respected without any unnecessary delay.
Asked by: Carla Lockhart (Democratic Unionist Party - Upper Bann)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that patients have timely access to innovative cancer medicines.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
In England, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical and cost effectiveness. The NHS is legally required to fund NICE recommended medicines, normally within three months of final guidance, and cancer medicines are eligible for funding from the point of a positive draft NICE recommendation. NICE aims wherever possible to issue guidance on new medicines close to the time of licensing to ensure that patients are able to benefit from rapid access to clinically and cost effective new medicines.
The Life Sciences Sector Plan sets out the measures we are taking that will mean that patients are able to access medicines three to six months faster, including improved alignment between the Medicines and Healthcare products Regulatory Agency’s decisions and NICE guidance publication.
In England in 2024/25, 93% of NICE recommendations for cancer treatments were positive. Positive includes recommended, optimised, recommended in the cancer drugs fund (CDF), and optimised in the CDF.
Health is a devolved matter and as such it would not be appropriate for me to comment on access to medicines within the devolved administrations.
Asked by: Carla Lockhart (Democratic Unionist Party - Upper Bann)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department plans make an assessment of the use of (a) fibrous forms of talc, (b) tremolite and (c) actinolite in products used by the NHS.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
From a medicines perspective, additives in medicines, termed excipients, are required to comply with the standards laid down in pharmacopeial monographs and can only be included in medicinal products at levels that are considered to be safe.
The Medicines and Healthcare products Regulatory Agency is aware of general concerns in relation to the presence of asbestos in talcum powder. However, pharmaceutical grade talc has strict controls on the presence of asbestos. The British Pharmacopeia monograph for Purified Talc states that “Talc derived from deposits that are known to contain associated asbestos is not suitable for pharmaceutical use”. Furthermore, testing is required to confirm the absence of asbestos.
NHS Supply Chain procurement activities require suppliers to comply with United Kingdom regulatory requirements such as the United Kingdom Accreditation Service or international equivalent accreditation for International Organization for Standardization (ISO) 9001 and ISO 13485, to ensure that products procured under NHS Supply Chain frameworks and used within the National Health Service in England are subject to rigorous safety assessments.
Asked by: Carla Lockhart (Democratic Unionist Party - Upper Bann)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the introduction of telemedicine for first-trimester abortions on the number of criminal prosecutions in the last five years.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government has not made an assessment on the connection between the number of prosecutions for unlawful abortions and the availability of telemedicine for early medical abortion. As with other matters of conscience, abortion is an issue on which the Government adopts a neutral stance. Parliament decides the circumstances under which abortion can legally be undertaken.
In 2022, Parliament voted to amend the Abortion Act 1967 to allow eligible women in England and Wales to take one or both pills for early medical abortion up to 10 weeks at home, following a consultation with a clinician either in person, by telephone or by electronic means. The Department works closely with NHS England, the Care Quality Commission, and abortion providers to ensure that abortions are provided safely, in accordance with the legal framework set by the Abortion Act 1967.
Abortion continues to be a very safe procedure for which major complications are rare at all gestations. The evidence-base for home use of early medical abortion pills has been assessed by leading statutory and professional organisations and it is recognised to be a safe procedure in evidence-based guidance, including the World Health Organisation’s abortion care guideline, the Royal College of Obstetricians and Gynaecologists 2022 report on best practice in abortion care and the National Institute for Health and Care Excellence clinical guidelines on abortion care.
Asked by: Carla Lockhart (Democratic Unionist Party - Upper Bann)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of decriminalising abortion on (a) levels of public confidence in the protection of unborn children and (b) societal attitudes towards the value of life.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
No assessment has been made. It is for Parliament to decide the circumstances under which abortions should take place. As with other matters of conscience, abortion is an issue on which the Government adopts a neutral stance and allows hon. Members to vote according to their moral, ethical or religious beliefs.